Literature DB >> 31849219

β-Arrestin-2 BRET Biosensors Detect Different β-Arrestin-2 Conformations in Interaction with GPCRs.

Atsuro Oishi1, Julie Dam1, Ralf Jockers1.   

Abstract

β-Arrestins are critical regulators of G protein-coupled receptors (GPCRs) that desensitize G protein signaling, promote receptor internalization, and initiate signaling on their own. Recent structural findings indicate that β-arrestins adopt different conformations upon interaction with agonist-activated GPCRs. Here, we established a β-arrestin-2 conformational bioluminescence resonance energy transfer (BRET) sensor composed of the bright Nanoluc BRET donor and the red-shifted CyOFP1 BRET acceptor. The sensor monitors early intramolecular conformational changes of β-arrestin-2 in complex with a wide panel of different class A and class B GPCRs upon agonist activation and with orphan GPCRs known to spontaneously recruit β-arrestin-2. The introduction of the R170E mutant in the β-arrestin-2 sensor allowed the detection of a partially active β-arrestin-2 conformation, which is not dependent on receptor phosphorylation, while the deletion of the β-arrestin-2 finger-loop region detected the "tail-conformation" corresponding to the interaction of β-arrestin with the carboxyl-terminal domain of GPCRs. The new sensors combine the advantages of the BRET technique in terms of sensitivity, robustness, and suitability for real-time measurements with a high responsiveness toward early conformational changes to help to elucidate the different conformational states of β-arrestins associated with GPCR activation in living cells.

Entities:  

Keywords:  BRET; CyOFP1; GPCR; Nluc; arrestin; conformational change; orphan receptor

Year:  2019        PMID: 31849219     DOI: 10.1021/acssensors.9b01414

Source DB:  PubMed          Journal:  ACS Sens        ISSN: 2379-3694            Impact factor:   7.711


  10 in total

1.  Measuring Protein-Protein Interactions of Melatonin Receptors by Bioluminescence Resonance Energy Transfer (BRET).

Authors:  Atsuro Oishi; Ralf Jockers
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Seeing (and Using) the Light: Recent Developments in Bioluminescence Technology.

Authors:  Anna C Love; Jennifer A Prescher
Journal:  Cell Chem Biol       Date:  2020-08-13       Impact factor: 8.116

3.  Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors.

Authors:  Ben Jones; Emma Rose McGlone; Zijian Fang; Phil Pickford; Ivan R Corrêa; Atsuro Oishi; Ralf Jockers; Asuka Inoue; Sunil Kumar; Frederik Görlitz; Chris Dunsby; Paul M W French; Guy A Rutter; Tricia Tan; Alejandra Tomas; Stephen R Bloom
Journal:  J Biol Chem       Date:  2020-12-04       Impact factor: 5.157

4.  A genetically encoded BRET-based SARS-CoV-2 Mpro protease activity sensor.

Authors:  Anupriya M Geethakumari; Wesam S Ahmed; Saad Rasool; Asma Fatima; S M Nasir Uddin; Mustapha Aouida; Kabir H Biswas
Journal:  Commun Chem       Date:  2022-09-28

Review 5.  Genetically encoded fluorescent biosensors for GPCR research.

Authors:  Hyunbin Kim; In-Yeop Baek; Jihye Seong
Journal:  Front Cell Dev Biol       Date:  2022-09-29

Review 6.  Coelenterazine-Dependent Luciferases as a Powerful Analytical Tool for Research and Biomedical Applications.

Authors:  Vasilisa V Krasitskaya; Eugenia E Bashmakova; Ludmila A Frank
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

Review 7.  Multiple GPCR Functional Assays Based on Resonance Energy Transfer Sensors.

Authors:  Yiwei Zhou; Jiyong Meng; Chanjuan Xu; Jianfeng Liu
Journal:  Front Cell Dev Biol       Date:  2021-05-10

8.  Acylation of the Incretin Peptide Exendin-4 Directly Impacts Glucagon-Like Peptide-1 Receptor Signaling and Trafficking.

Authors:  Maria Lucey; Tanyel Ashik; Amaara Marzook; Yifan Wang; Joëlle Goulding; Atsuro Oishi; Johannes Broichhagen; David J Hodson; James Minnion; Yuval Elani; Ralf Jockers; Stephen J Briddon; Stephen R Bloom; Alejandra Tomas; Ben Jones
Journal:  Mol Pharmacol       Date:  2021-07-27       Impact factor: 4.054

Review 9.  The therapeutic potential of GLP-1 receptor biased agonism.

Authors:  Ben Jones
Journal:  Br J Pharmacol       Date:  2021-05-20       Impact factor: 8.739

10.  Evaluation of efficacy- versus affinity-driven agonism with biased GLP-1R ligands P5 and exendin-F1.

Authors:  Amaara Marzook; Shiqian Chen; Phil Pickford; Maria Lucey; Yifan Wang; Ivan R Corrêa; Johannes Broichhagen; David J Hodson; Victoria Salem; Guy A Rutter; Tricia M Tan; Stephen R Bloom; Alejandra Tomas; Ben Jones
Journal:  Biochem Pharmacol       Date:  2021-06-12       Impact factor: 5.858

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.